Our present results indicate that in SAMP10 mice, sarcopenia can be ameliorated by YBMT via the improvement of protein anabolic responses, the imbalance between muscle apoptosis and proliferation, and mitochondrial biogenesis that are partially mediated by GDF‐11 signalling. Here, GDF11 is linked to sarcopenia.